Annual Retained Earnings
-$356.21 M
-$29.36 M-8.98%
March 31, 2024
Summary
- As of February 26, 2025, VTGN annual retained earnings is -$356.21 million, with the most recent change of -$29.36 million (-8.98%) on March 31, 2024.
- During the last 3 years, VTGN annual retained earnings has fallen by -$136.37 million (-62.03%).
- VTGN annual retained earnings is now -731345.59% below its all-time high of -$48.70 thousand, reached on December 31, 2009.
Performance
VTGN Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$394.00 M
-$14.09 M-3.71%
December 31, 2024
Summary
- As of February 26, 2025, VTGN quarterly retained earnings is -$394.00 million, with the most recent change of -$14.09 million (-3.71%) on December 31, 2024.
- Over the past year, VTGN quarterly retained earnings has dropped by -$27.05 million (-7.37%).
- VTGN quarterly retained earnings is now -808928.75% below its all-time high of -$48.70 thousand, reached on December 31, 2009.
Performance
VTGN Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
VTGN Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.0% | -7.4% |
| 3 y3 years | -62.0% | -7.4% |
| 5 y5 years | -96.7% | -7.4% |
VTGN Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -62.0% | at low | -57.0% | at low |
| 5 y | 5-year | -96.7% | at low | -98.3% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
VistaGen Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | -$394.00 M(+3.7%) |
| Sep 2024 | - | -$379.91 M(+3.5%) |
| Jun 2024 | - | -$366.95 M(+3.0%) |
| Mar 2024 | -$356.21 M(+9.0%) | -$356.21 M(+2.7%) |
| Dec 2023 | - | -$346.69 M(+1.9%) |
| Sep 2023 | - | -$340.34 M(+2.0%) |
| Jun 2023 | - | -$333.75 M(+2.1%) |
| Mar 2023 | -$326.85 M(+22.1%) | -$326.85 M(+3.9%) |
| Dec 2022 | - | -$314.62 M(+3.2%) |
| Sep 2022 | - | -$304.86 M(+6.1%) |
| Jun 2022 | - | -$287.38 M(+7.4%) |
| Mar 2022 | -$267.60 M(+21.7%) | -$267.60 M(+6.7%) |
| Dec 2021 | - | -$250.92 M(+4.4%) |
| Sep 2021 | - | -$240.38 M(+5.6%) |
| Jun 2021 | - | -$227.59 M(+3.5%) |
| Mar 2021 | -$219.84 M(+8.9%) | -$219.84 M(+2.9%) |
| Dec 2020 | - | -$213.63 M(+2.5%) |
| Sep 2020 | - | -$208.33 M(+1.6%) |
| Jun 2020 | - | -$205.03 M(+1.5%) |
| Mar 2020 | -$201.91 M(+11.5%) | -$201.91 M(+1.6%) |
| Dec 2019 | - | -$198.64 M(+3.1%) |
| Sep 2019 | - | -$192.68 M(+2.8%) |
| Jun 2019 | - | -$187.34 M(+3.4%) |
| Mar 2019 | -$181.13 M | -$181.13 M(+3.3%) |
| Dec 2018 | - | -$175.41 M(+4.3%) |
| Sep 2018 | - | -$168.19 M(+4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | -$160.76 M(+2.7%) |
| Mar 2018 | -$156.54 M(+10.2%) | -$156.54 M(+2.7%) |
| Dec 2017 | - | -$152.47 M(+2.1%) |
| Sep 2017 | - | -$149.26 M(+3.5%) |
| Jun 2017 | - | -$144.26 M(+1.6%) |
| Mar 2017 | -$142.00 M(+7.8%) | -$142.00 M(+1.8%) |
| Dec 2016 | - | -$139.45 M(+1.9%) |
| Sep 2016 | - | -$136.81 M(+2.3%) |
| Jun 2016 | - | -$133.71 M(+1.5%) |
| Mar 2016 | -$131.74 M(+55.9%) | -$131.74 M(+6.9%) |
| Dec 2015 | - | -$123.24 M(+1.8%) |
| Sep 2015 | - | -$121.09 M(+6.2%) |
| Jun 2015 | - | -$114.05 M(+34.9%) |
| Mar 2015 | -$84.52 M(+19.7%) | -$84.52 M(+7.9%) |
| Dec 2014 | - | -$78.30 M(+1.4%) |
| Sep 2014 | - | -$77.21 M(+2.7%) |
| Jun 2014 | - | -$75.19 M(+6.4%) |
| Mar 2014 | -$70.64 M(>+9900.0%) | -$70.64 M(+20.6%) |
| Sep 2012 | - | -$58.56 M(+3.5%) |
| Jun 2012 | - | -$56.61 M(+9.4%) |
| Dec 2011 | - | -$51.74 M(+9.5%) |
| Sep 2011 | - | -$47.24 M(+5.0%) |
| Jun 2011 | - | -$44.98 M(>+9900.0%) |
| Mar 2011 | - | -$63.00 K(+9.4%) |
| Dec 2010 | -$57.60 K(+18.3%) | -$57.60 K(+18.3%) |
| Dec 2009 | -$48.70 K | -$48.70 K |
FAQ
- What is VistaGen Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for VistaGen Therapeutics?
- What is VistaGen Therapeutics annual retained earnings year-on-year change?
- What is VistaGen Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for VistaGen Therapeutics?
- What is VistaGen Therapeutics quarterly retained earnings year-on-year change?
What is VistaGen Therapeutics annual retained earnings?
The current annual retained earnings of VTGN is -$356.21 M
What is the all time high annual retained earnings for VistaGen Therapeutics?
VistaGen Therapeutics all-time high annual retained earnings is -$48.70 K
What is VistaGen Therapeutics annual retained earnings year-on-year change?
Over the past year, VTGN annual retained earnings has changed by -$29.36 M (-8.98%)
What is VistaGen Therapeutics quarterly retained earnings?
The current quarterly retained earnings of VTGN is -$394.00 M
What is the all time high quarterly retained earnings for VistaGen Therapeutics?
VistaGen Therapeutics all-time high quarterly retained earnings is -$48.70 K
What is VistaGen Therapeutics quarterly retained earnings year-on-year change?
Over the past year, VTGN quarterly retained earnings has changed by -$27.05 M (-7.37%)